ÐÂÎÅ×ÊѶ
KU¿áÓιÙÍøÔÑÐÒ©MCR»·ëÄÆô·¢ÌÇÄò²¡ÊÓÍøĤ²¡±ä¶àͨ·ҽÖÎÐÂÕ½Êõ £¬Í»ÆÆ¿¹VEGFÒ©Îï¾ÖÏÞ½ø¾üDZÔÚÊý°ÙÒÚÐÂÈü·
ÈÕÆÚ£º
2026Äê04ÔÂ02ÈÕ 15:00
ÌÇÄò²¡ÊÓÍøĤ²¡±ä£¨DR£©ÊÇÌÇÄò²¡×î³£¼ûÇÒÑϳÁµÄ΢Ѫ¹Ü²¢·¢Ö¢Ö®Ò» £¬Ò²ÊǸ÷´ºÇïÈËȺ£¨Ô̺¬¶ùͯ¡¢¹¤×÷³ÉÄêÈ˺ÍÀÏÄêÈË£©ÖØÒªµÄÖÂäÔÒò1¡£2020Äê £¬È«ÇòÓг¬¹ý1.03ÒÚÈËÊܵ½ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÓ°Ïì £¬Ô¤¼Æµ½2045ÄêÕâÒ»Êý×Ö½«ÉÏÉýµ½1.61ÒÚÈË1¡£ÕâÖðÒ»Á¬¶àÄêµÄÁÙ´²ðó¼² £¬Õý±»Ò»ÏîÖйúÔ´´Í»ÆÆËùº³¶¯¡£½üÈÕ £¬¾ÝϤKU¿áÓιÙÍø£¨ÒÔϼò³Æ“KU¿áÓιÙÍø”£©×ÔÖ÷Ñз¢µÄ´´ÐÂÓ×·Ö×Ó»·ëÄÒ©ÎMCR»·ëÄ£©ÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÒ½ÖÎÁìÓò»ñµÃÁÙ´²Ç°³Á´óÍ»ÆÆ¡£
Ò»¡¢ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÒ½ÖÎÀ§¾³
ÌÇÄò²¡ÊÓÍøĤ²¡±äÊÇÒ»ÖÖ½øÕ¹ÐÔÑÛ²¿¼²²¡ £¬³Ö¾Ã¸ßѪÌǻᵼÖÂÊÓÍøĤ΢Ѫ¹ÜΣÏÕ £¬Òý·¢ÊÓÍøĤȱѪȱÑõ £¬½ø¶øÍƽø²¡ÀíÐÔÐÂÉúѪ¹ÜÐÎ³É £¬Ôì³ÉÊÓÍøĤÔöÖ³ÐÔ²¡±ä2¡£Ä¿Ç° £¬¿¹VEGFÒ©ÎïºÍ¼¤¹â¹âÄýÊõÊÇÒ½ÖÎDRµÄ½ð³ß¶ÈÁÆ·¨ £¬µ«´æÔÚ±ØҪƵÈÔÑÛÄÚ×¢Éä¡¢²¿ÃÅ»¼ÕßÓ¦´ðÇ·°²µÈÎÊÌâ £¬Ø½ÐèÐÂÐÍÒ½ÖÎÕ½Êõ1¡£
½üÄêÀ´µÄ×êÑз¢ÏÖ £¬ºÚƤÖÊËØϵͳ£¨Melanocortin System£©ÔÚµ÷½ÚÑ×Ö¢·´Ó³¡¢Íƽø×éÖ¯½¨¸´ºÍά³ÖÄÚ»·¾³²»±ä·½Ãæ²ûÑï¹Ø¼ü×÷ÓÃ3 £¬ÎªDRÒ½ÖÎÌṩÁËÐÂ˼·¡£
¶þ¡¢KU¿áÓιÙÍøMCR»·ëÄ£º¶ÔÊÓÍøĤ½á¹¹±£»¤³ÉЧÏÔÖø
KU¿áÓιÙÍøÑз¢µÄMCR»·ëÄÔÚDB/DBÌÇÄò²¡Ó×ÊóÄ£ÐÍÖвû·¢³öÏÔÖøµÄÊÓÍøĤ±£»¤×÷Óá£
³¢ÊÔÁ˾ÖÏÔʾ £¬DB/DBÄ£ÐÍÓ×ÊóµÄÄں˲㣨INL£©ºÍ±íºË²ã£¨ONL£©ºñ¶ÈÏÔÖø±ä±¡ £¬ÕâÊÇÌÇÄò²¡ÒýÆðÊÓÍøĤ±äÐԵĵäÐÍÌص㡣¶ø¾¹ýMCR»·ëÄÒ½ÖÎºó £¬ÊÓÍøĤ½á¹¹µÃµ½ÏÔÖø¸ÄÉÆ£º
1. MCR»·ëĵͼÁÁ¿×éºÍ¸ß¼ÁÁ¿×éÏÔʾ¼ÁÁ¿ÒÀÀµÐÔµÄÊÓÍøĤ½á¹¹¸´Ô£»
2. MCR»·ëĸ߼ÁÁ¿×éµÄONLºñ¶È¸´Ô¿¿½üÕý³£Ë®Æ½¡£
Èý¡¢¶à³Á»úÔìÐͬ×÷ÓÃ
KU¿áÓιÙÍøMCR»·ëĵÄÖ÷ÌâÓÅÊÆÔÚÓÚÆä¶à°Ðµã×÷ÓûúÔì¡£Ëü·ÂÕÕÁËÄÚÔ´ÐÔºÚƤÖÊËØ£¨Èçα- MSH£©µÄÉúÀíÖ°ÄÜ £¬Í¨¹ý¼¤»îÑÛÖеĺÚƤÖÊËØÊÜÌå £¬´ÓÑ×Ö¢¡¢Ñª¹Ü¡¢·®ÀéºÍÉñ¾µÈ¶à¸ö¹Ø¼ü»·½ÚÐͬ²ûÑï×÷ÓÃ1, 4¡£
ǿЧ¿¹Ñ×ÓëÃâÒßµ÷½Ú
ÌÇÄò²¡ÊÓÍøĤ²¡±äÐÔÖÊÉÏÊÇÒ»ÖÖÂýÐԵͶÈÑ×Ö¢ÐÔ¼²²¡¡£×êÑÐ֤ʵ £¬¼¤»îMCR £¬³ö¸ñÊÇMC1R £¬¿ÉÄÜÏÔÖøÒÖÔìºËÒò×ÓκB£¨NF-κB£©µÈ¹Ø¼ü´ÙÑ×ÐźÅͨ·µÄ»î»¯5¡£Õâµ¼Ö¶àÖÖ´ÙÑ×Òò×Ó£¨ÈçTNF-α, IL-1β, IL-6£©ºÍÇ÷»¯Òò×Ó£¨ÈçMIP-1α, MIP-2£©µÄ±í°×ϵ÷4¡£¸ü³ÁÒªµÄÊÇ £¬MCR¼¤°º¼ÁÄÜÓÕµ¼ÓµÓп¹Ñ×Ö°Äܵĵ÷½ÚÐÔTϸ°û£¨Treg£©µÄÌìÉú £¬²¢Íƽø¿¹Ñ×ϸ°ûÒò×ÓIL-10µÄ±í°× £¬´Ó¶ø½«ÃâÒß·´Ó³´Ó·ÛËéÐԵĴÙÑ×״̬תÏò±£»¤ÐԵĿ¹Ñ׺ͽ¨¸´×´Ì¬4, 5¡£´Ë±í £¬ÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÄ£ÐÍÖÐ £¬MCR¼¤°º¼Á»¹±»Ö¤Ã÷Äܹ»Íƽø¾ÞÊÉϸ°û´Ó´ÙÑ×µÄM1±íÐÍÏò¿¹Ñס¢´Ù½¨¸´µÄM2±íÐͼ«»¯ £¬ÕâÓÐÖúÓÚÑ×Ö¢µÄÏûÍ˺Í×éÖ¯½¨¸´4¡£
¿¹Ñª¹ÜÌìÉúÓë¼õÇáÉø©
³ýÁËÒÖÔìÑ×Ö¢ £¬MCR¼¤°º¼Á¿ÉÄÜÖ±½Ó×÷ÓÃÓÚѪ¹Üϵͳ¡£×êÑÐÅú×¢ £¬¼¤»îMC4RÄܹ»Þ׿¹ÊÓÍøĤ΢Ѫ¹ÜÄÚƤϸ°ûµÄ¸ßͨ͸ÐÔ5¡£Í¬Ê± £¬¼¤°ºMC1RÄÜÏÔÖø½µµÍÊÓÍøĤÖÐѪ¹ÜÄÚƤ³É³¤Òò×Ó£¨VEGF£©µÄˮƽ £¬ÕâÊÇÇý¶¯²¡ÀíÐÔÐÂÉúѪ¹ÜÐγɺÍѪ¹ÜÉø©µÄ¹Ø¼üÒò×Ó4¡£ÕâÖÖͨ¹ýµ÷½ÚÄÚÔ´ÐÔͨ·À´ÒÖÔìVEGFµÄ¹ÖÒì»úÔì £¬ÓëÏÖÓеĿ¹VEGFÒ©ÎïÐγɻ¥²¹ £¬¿ÉÄÜΪ½â¾ö¿¹VEGFÒ½ÖÎÄÍÒ©ÐÔÎÊÌâÌṩÐÂÕ½Êõ¡£
²»±äѪ-ÊÓÍøĤ·®Àé
Ѫ-ÊÓÍøĤ·®ÀéµÄ·ÛËéÊÇÌÇÄò²¡ÊÓÍøĤ²¡±äѪ¹ÜÉø©ºÍÊÓÍøĤˮÖ׵IJ¡Àí»ù´¡¡£MCR¼¤»î¿ÉÏÔÖøÔö³¤ÊÓÍøĤÖÐçÇÃÜÏνӵ°°×£¨ÈçOccludin£©µÄ±í°× £¬´Ó¶ø´Ó½á¹¹ÉϼӹÌѪ-ÊÓÍøĤ·®Àé £¬Ï÷¼õѪ½¬³É·ÖµÄÉø©4¡£
Ö±½Óϸ°û±£»¤Ó뿹µòÍö
MCRµÄϸ°û±£»¤×÷Óó¬¹ýÁËѪ¹ÜºÍÑ×֢ϸ°û £¬Ö±½Ó»Ý¼°ÊÓÍøĤÉñ¾Ôª¡£α-MSHÒѱ»Ö¤Ã÷¿ÉÄÜͨ¹ý¼¤»îMC1R¼°ÆäÏÂÓεÄAkt/mTORºÍErk1/2 MAPKÐźÅͨ· £¬±£»¤ÊÓÍøĤɫËØÉÏƤϸ°ûÃâÊÜÑõ»¯Ó¦¼¤ÓÕµ¼µÄµòÍö5¡£ÔÚȱѪ/ÔÙ¹àעΣÏÕÄ£ÐÍÖÐ £¬MCR¼¤°º¼ÁÏÔʾ³ö¶ÔÊÓÍøĤÉñ¾½Úϸ°ûµÄÏÔÖø±£»¤×÷Óà £¬Ï÷¼õϸ°ûµòÍö £¬Õâ¶ÔÓÚÔ¤·ÀÌÇÄò²¡ÊÓÍøĤ²¡±äÖеÄÉñ¾±äÐÔÖÁ¹Ø³ÁÒª¡£
ËÄ¡¢Ô¶¾°Õ°Íû
ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÒ½ÖÎÕý´¦ÔÚÒ»¸öתÐÍÆÚ £¬´Óµ¥Ò»µÄVEGFÒÖÔìÏò¶à°Ðµã¡¢È«·½Î»±£»¤µÄ·½Ïò·¢Õ¹¡£KU¿áÓιÙÍøµÄMCR»·ëÄÒ©Îïƾ½èÆä¹ÖÒìµÄ×÷ÓûúÔìºÍÁîÈ˹ÄÀøµÄÁÙ´²Ç°Êý¾Ý £¬ÓÐÍû³ÉΪÕâÒ»ÁìÓòµÄ³Á°õ²úÆ· £¬ÎªÈ«ÇòÊýÒÚDR»¼Õß´øÀ´ÐµÄÒ½ÖÎÑ¡Ôñ¡£
ÎÄÕÂÆðÔ´ÓÚҩʱÆÚ¹«¼ÒºÅ
²Î¿¼Îļþ
1. Seo, H., Park, S. J., & Song, M. (2025). Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies. Cells, 14(5), 376. https://doi.org/10.3390/cells14050376
2. áÓÖÝÉòÊÏÑÛ¿ÆÒ½Ôº£¨2024£©. ÌÇÄò²¡ÐÔÊÓÍøĤ²¡±ä¿ÆÆÕ. ΢ÐŹ«¼ÒºÅ. Available at:https://mp.weixin.qq.com/s?__biz=MzA5NDI4NTcyNw==&mid=2653585500&idx=1&sn=87cf362b3300a3db891c4c19b8296833&chksm=8a0f495e1bf34e32bdd0e087b3d55b6541aac5cd462a1dacdd8b0a2fc8e71fea61b44b2d1bb7&scene=27 £¨Accessed: September 28, 2025£©
3. Kayne, P. et al. (2025). Activating the Melanocortin System Resolves Inflammation, Reduces VEGF Signaling in Diabetic Retinopathy (DR), and Provides Retinal Ganglion Cell (RGC) Protection. Available at:https://palatin.com/wpcontent/uploads/2025/05/PosterPTN_PL9654_Diabetic_RetinopathyARVO_2025050825.pdf (Accessed: September 28, 2025)
4. Rossi, S., Maisto, R., Gesualdo, C., Trotta, M. C., Ferraraccio, F., Kaneva, M. K., Getting, S. J., Surace, E., Testa, F., Simonelli, F., Grieco, P., Merlino, F., Perretti, M., D'Amico, M., & Di Filippo, C. (2016). Activation of Melanocortin Receptors MC 1 and MC 5 Attenuates Retinal Damage in ExperimentalDiabeticRetinopathy. Mediatorsofinflammation,2016, 7368389. https://doi.org/10.1155/2016/7368389
5. Wang, S., Kahale, F., Naderi, A., Surico, P. L., Yin, J., Dohlman, T., Chen, Y., & Dana, R. (2024). Therapeutic Effects of Stimulating the Melanocortin Pathway in Regulating Ocular Inflammation and Cell Death.Biomolecules,14(2),169. https://doi.org/10.3390/biom14020169
ÓйØÍƼö
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ºâÑô